Cargando…

The Assessment of Risk and Predictors of Sleep Disorders in Patients with Psoriasis—A Questionnaire-Based Cross-Sectional Analysis

Psoriasis is a chronic, inflammatory skin disease affecting 2–4% of the general population. Accompanying subjective symptoms (pruritus or pain) may cause decreased life quality including sleep disorders (SD). Sixty psoriatic patients fulfilled the following questionnaires: Pittsburgh Sleep Quality I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nowowiejska, Julia, Baran, Anna, Lewoc, Marta, Grabowska, Paulina, Kaminski, Tomasz W., Flisiak, Iwona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916004/ https://www.ncbi.nlm.nih.gov/pubmed/33572270 http://dx.doi.org/10.3390/jcm10040664

Ejemplares similares

Assessment of Life Quality, Stress and Physical Activity Among Patients with Psoriasis
por: Nowowiejska, Julia, et al.
Publicado: (2021)

Mutual Relationship Between Sleep Disorders, Quality of Life and Psychosocial Aspects in Patients With Psoriasis
por: Nowowiejska, Julia, et al.
Publicado: (2021)

Galectin-3 as a Novel Multifaceted and Not Only Cardiovascular Biomarker in Patients with Psoriasis with Regard to Systemic Treatment—Preliminary Data
por: Baran, Anna, et al.
Publicado: (2022)

Aberrations in Lipid Expression and Metabolism in Psoriasis
por: Nowowiejska, Julia, et al.
Publicado: (2021)

Psoriasis and neurodegenerative diseases—a review
por: Nowowiejska, Julia, et al.
Publicado: (2022)

Circulating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus—Preliminary Data
por: Baran, Anna, et al.
Publicado: (2021)

Fatty Acid-Binding Proteins in Psoriasis—A Review
por: Nowowiejska, Julia, et al.
Publicado: (2022)

Circulating ANGPTL8 as a Potential Protector of Metabolic Complications in Patients with Psoriasis
por: Baran, Anna, et al.
Publicado: (2023)

Higher Serum Selenoprotein P Level as a Novel Inductor of Metabolic Complications in Psoriasis
por: Baran, Anna, et al.
Publicado: (2020)

Serum Cholesteryl Ester Transfer Protein (CETP) and Sortilin (SORT) in Patients with Psoriasis with Relation to Systemic Treatment
por: Nowowiejska, Julia, et al.
Publicado: (2022)

Potential Predictive Value of Serum Pentraxin 3 and Paraoxonase 1 for Cardiometabolic Disorders Development in Patients with Psoriasis—Preliminary Data
por: Baran, Anna, et al.
Publicado: (2022)

Decreased levels of vaspin and its potential association with cardiometabolic risk in patients with psoriasis: preliminary results
por: Kiluk, Paulina, et al.
Publicado: (2021)

The Potential Role of Serum Tau Protein (MAPT), Neuronal Cell Adhesion Molecule (NrCAM) and Neprilysin (NEP) in Neurodegenerative Disorders Development in Psoriasis—Preliminary Results
por: Baran, Anna, et al.
Publicado: (2022)

Evaluation of Plasma Concentrations of Galectins-1, 2 and 12 in Psoriasis and Their Clinical Implications
por: Nowowiejska, Julia, et al.
Publicado: (2023)

Tinea Incognito—A Great Physician Pitfall
por: Nowowiejska, Julia, et al.
Publicado: (2022)

Baboon syndrome
por: Nowowiejska, Julia, et al.
Publicado: (2020)

Lipid Aberrations in Lichen Planus
por: Nowowiejska, Julia, et al.
Publicado: (2022)

Lipid Alterations and Metabolism Disturbances in Selected Inflammatory Skin Diseases
por: Nowowiejska, Julia, et al.
Publicado: (2023)

Gasdermin D (GSDMD) Is Upregulated in Psoriatic Skin—A New Potential Link in the Pathogenesis of Psoriasis
por: Nowowiejska, Julia, et al.
Publicado: (2023)

Angiopoietin-Like 4 (ANGPTL4) in Patients with Psoriasis, Lichen Planus and Vitiligo—A Pilot Study from the Bialystok+ Polish Longitudinal University Study
por: Nowowiejska, Julia, et al.
Publicado: (2022)

Tumor Necrosis Factor (TNF) α, Endothelin (ET) 1 and α1-Acid Glycoprotein (AGP) as Potential Urine and Serum Markers of Metabolic Complications in Psoriasis?
por: Nowowiejska, Julia, et al.
Publicado: (2023)

Gasdermin E (GSDME)—A New Potential Marker of Psoriasis and Its Metabolic Complications: The First Combined Study on Human Serum, Urine and Tissue
por: Nowowiejska, Julia, et al.
Publicado: (2023)

Crosstalk between Serum and Skin Sphingolipids in Psoriasis
por: Matwiejuk, Mateusz, et al.
Publicado: (2023)

The Level of FGF 21 as a New Risk Factor for the Occurrence of Cardiometabolic Disorders amongst the Psoriatic Patients
por: Kiluk, Paulina, et al.
Publicado: (2019)

Great hopes or disappointment – a survey-based study on patients’ and doctors’ perception of telemedicine during the COVID-19 pandemic in Poland
por: Stepaniuk, Anna, et al.
Publicado: (2022)

Behçet’s Disease in a Polish Patient: A Case Report
por: Nowowiejska, Julia, et al.
Publicado: (2021)

Methotrexate Decreases the Level of PCSK9—A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data
por: Krahel, Julita Anna, et al.
Publicado: (2020)

Fatty Acid-Binding Protein 7 (FABP-7), Glutamic Acid and Neurofilament Light Chain (NFL) as Potential Markers of Neurodegenerative Disorders in Psoriatic Patients—A Pilot Study
por: Nowowiejska, Julia, et al.
Publicado: (2022)

Elevated circulating Krüppel-like factor 4 level as a novel independent marker of the proatherogenic risk in patients with psoriasis: a preliminary study
por: Baran, Anna, et al.
Publicado: (2020)

Liver fatty acid-binding protein might be a predictive marker of clinical response to systemic treatment in psoriasis
por: Baran, Anna, et al.
Publicado: (2019)

Effect of psoriasis activity on serum adiponectin and leptin levels
por: Baran, Anna, et al.
Publicado: (2015)

Proprotein Convertase Subtilisin/Kexin Type 9, Angiopoietin-Like Protein 8, Sortilin, and Cholesteryl Ester Transfer Protein—Friends of Foes for Psoriatic Patients at the Risk of Developing Cardiometabolic Syndrome?
por: Krahel, Julita Anna, et al.
Publicado: (2020)

Kynurenine Pathway in Psoriasis—a Promising Link?
por: Stepaniuk, A., et al.
Publicado: (2023)

Maskne—Dermatosis of a Pandemic. A Survey on the Impact of PPE on Facial Skin Among HCW and N-HCW in Poland
por: Malczynska, Izabela U., et al.
Publicado: (2022)

Serum fatty acid profile in psoriasis and its comorbidity
por: Myśliwiec, Hanna, et al.
Publicado: (2017)

The Role of Sphingolipids in the Pathogenesis of Psoriasis
por: Matwiejuk, Mateusz, et al.
Publicado: (2022)

The Interplay between Bioactive Sphingolipids in the Psoriatic Skin and the Severity of the Disease
por: Matwiejuk, Mateusz, et al.
Publicado: (2023)

Effects of Hypolipidemic Drugs on Psoriasis
por: Matwiejuk, Mateusz, et al.
Publicado: (2023)

Sleep Disorders and Psoriasis: An Update
por: HALIOUA, Bruno, et al.
Publicado: (2022)

Questionnaire-Based Study Evaluating the Hand Hygiene Practices and the Impact of Disinfection in the COVID-19 Pandemic on Hand Skin Conditions in Poland
por: Polecka, Agnieszka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_760r1qdg03nm2n4id63ja60trv